October 2023 - PharmaTimes

Published on 27 September 2023

Description:

New PharmaTimes is out now and on the campaign trail! With an eye on the general election, we look at which party can get our health service our of intensive care and into the arena of functionality. Yes, this month’s tome is all about positive (and desperately needed) change! We also focus of the inseparable connection between mental health and physical conditions. In addition, tech, AI and data will take us on a magical mystery tour of possibilities and potential throughout the pharmaverse. Meanwhile, the challenges of clinical trial redesign, personalised healthcare and precision medicine complete all-encompassing manifesto.

Categories:

PharmaTimes

27 articles from this collection:

Cover

2 - FlyPharma Europe

3 - From the editor

This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration.

4-5 - Contents

6 - NEWS: Treatments

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.

7 - NEWS: Public Health

8 - NEWS: Research

9 - NEWS: Conditions

10-12 - ELECTION ‘24: In sickness and in health?

13 - TL ADVANCED CLINICAL: Write direction

14-15 - TL Galapagos: Talking heads

16-17 - DATA: Setting sights

18-19 - THE FUTURE - A new era beckons

20-21 - CLINICAL TRIALS - Trials of the century

22-23 - AI - Time travel technicians

24-25 - NHS: Mission possible

26-27 - CONDITIONS: Mind games

28 - PharmaTimes Award

29 - ADVANCED CLINICAL

29 - PharmaTimes

30-31 - CONDITIONS - Connect more

32-33 - PRECISION MEDICINE: On cancer’s trail

34-35 - JOINT WORKING - It’s complicated

36-37 - Your moves

38 - AI: Digital – this time it’s personal

39 - IPT Online

40 - PharmaRole

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com

https://pharmatimes.com/